IGF1 regulates PKM2 function through Akt phosphorylation

Cell Cycle

Volumn 14, Issue 10, 2015, Pages 1559-1567

  Salani, Barbara ^a,b   Ravera, Silvia ^a   Amaro, Adriana ^b   Salis, Annalisa ^a   Passalacqua, Mario ^a   Millo, Enrico ^a   Damonte, Gianluca ^a   Marini, Cecilia ^a,b,c   Pfeffer, Ulrich ^b   Sambuceti, Gianmario ^a,b   Cordera, Renzo ^a,b   Maggi, Davide ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CNR   (Italy)

Author keywords

HIF1 ; IGF1; IGFIR; PKM2

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; METFORMIN; PROTEIN KINASE B; PYRUVATE KINASE; PYRUVATE KINASE M2; SOMATOMEDIN C; STAT3 PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; GLUCOSE; HEXOKINASE; MEMBRANE PROTEIN; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG UPTAKE; ENERGY BALANCE; ENZYME ACTIVITY; GLUCOSE INTAKE; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIZE EXCLUSION CHROMATOGRAPHY; CELL LINE; CELL PROLIFERATION; CHEMISTRY; DIMERIZATION; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION;

CARRIER PROTEINS; CELL LINE; CELL PROLIFERATION; DIMERIZATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLYCOLYSIS; HEXOKINASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INSULIN-LIKE GROWTH FACTOR I; MEMBRANE PROTEINS; METFORMIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRUVATE KINASE; STAT3 TRANSCRIPTION FACTOR; THYROID HORMONES;

EID: 84943803984     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1026490     Document Type: Article

References (29)

1. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325-37; PMID: 21508971; http://dx. doi. org/10. 1038/nrc3038.
2. Yang W, Lu Z. Nuclear PKM2 regulates the Warburg effect. Cell Cycle 2013; 12: 3154-8; PMID: 24013426.
3. Wu S, Le H. Dual roles of PKM2 in cancer metabolism. Acta Biochim Biophys Sinica 2013; 45: 27-35; PMID: 23212076.
4. Wong N, Ojo D, Yan J, Tang D. PKM2 contributes to cancer metabolism. Cancer Lett 2014; 356: 184-91; PMID: 24508027; http://dx. doi. org/10. 1016/j. canlet. 2014. 01. 031.
5. Alderton GK. Alternative splicing: dose-dependent splicing. Nat Rev Cancer 2012; 12: 153-153.
6. Gupta V, Bamezai RNK. Human pyruvate kinase M2: A multifunctional protein. Protein Sci 2010; 19: 2031-44; PMID: 20857498.
7. Semenova G, Chernoff J. PKM2 enters the Morpheein academy. Mol Cell 2012; 45: 583-4; PMID: 22405271.
8. Wang LY, Liu YP, Chen LG, Chen YL, Tan L, Liu JJ, Jazag A, Ren JL, Guleng B. Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-Cadherin-dependent manner in gastric cancer cells. PLoS ONE 2013; 8: e67542; PMID: 23840737.
9. Dang CV. PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect. Sci Signal 2009; 2: pe75; PMID: 19920249.
10. Wang H-J, Hsieh Y-J, Cheng W-C, Lin C-P, Lin Y, Yang S-F, Chen C-C, Izumiya Y, Yu J-S, Kung H-J, et al. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1a-mediated glucose metabolism. Proc Natl Acad Sci U S A 2014; 111: 279-84; PMID: 24344305; http://dx. doi. org/10. 1073/pnas. 1311249111.
11. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, Cole RN, Pandey A, Semenza GL. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011; 145: 732-44; PMID: 21620138; http://dx. doi. org/10. 1016/j. cell. 2011. 03. 054.
12. Li W, Wang J, Chen QD, Qian X, Li Q, Yin Y, Shi ZM, Wang L, Lin J, Liu LZ, et al. Insulin Promotes Glucose Consumption via Regulation of miR-99a/mTOR/PKM2 Pathway. PLoS ONE 2013; 8: e64924; PMID: 23762265.
13. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell [Internet] 2007 [cited 2014 Dec 2]; 129: 1261-74. Available from: http://www. pubmedcen tral. nih. gov/articlerender. fcgi?artidD2756685&toolDpm centrez&rendertypeDabstract; PMID: 17604717.
14. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE [Internet] 2007 [cited 2014 Nov 6]; 2007: cm8. Available from: http://www. ncbi. nlm. nih. gov/pubmed/17925579.
15. Roberts DJ, Tan-Sah VP, Smith JM, Miyamoto S. Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem 2013; 288: 23798-806; PMID: 23836898; http://dx. doi. org/10. 1074/jbc. M113. 482026.
16. Kosugi M, Ahmad R, Alam M, Uchida Y, Kufe D. MUC1-C oncoprotein regulates glycolysis and pyruvate kinase m2 activity in cancer cells. PLoS One 2011; 6: e28234; PMID: 22140559; http://dx. doi. org/10. 1371/journal. pone. 0028234.
17. Salani B, Maffioli S, Hamoudane M, Parodi A, Ravera S, Passalacqua M, Alama A, Nhiri M, Cordera R, Maggi D. Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells. FASEB J 2012; 26: 788-98; PMID: 22038047.
18. Tsouko E, Khan AS, White MA, Han JJ, Shi Y, Merchant FA, Sharpe MA, Xin L, Frigo DE. Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis 2014; 3: e103; PMID: 24861463.
19. Jiang P, Du W, Wu M. Regulation of the pentose phosphate pathway in cancer. Protein Cell 2014; 5: 592-602; PMID: 25015087; http://dx. doi. org/10. 1007/s13238-014-0082-8.
20. Patra KC, Hay N. The pentose phosphate pathway and cancer. Trend Biochem Sci 2014; 39: 347-54; PMID: 25037503; http://dx. doi. org/10. 1016/j. tibs. 2014. 06. 005.
21. Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis CA, Aldape K, Cantley LC, Lu Z. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol [Internet] 2012; 14: 1295-304. Available from: http://www. pubmedcentral. nih. gov/articlerender. fcgi?artidD 3511602&toolDpmcentrez&rendertypeDabstract.
22. Yu Z, Zhao X, Huang L, Zhang T, Yang F, Xie L, Song S, Miao P, Zhao L, Sun X, et al. Proviral insertion in murine lymphomas 2 (PIM2) oncogene phosphorylates pyruvate kinase M2 (PKM2) and promotes glycolysis in cancer cells. J Biol Chem 2013; 288: 35406-16; PMID: 24142698; http://dx. doi. org/10. 1074/jbc. M113. 508226.
23. Hitosugi T, Kang S, Vander Heiden MG, Chung T-W, Elf S, Lythgoe K, Dong S, Lonial S, Wang X, Chen GZ, et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2009; 2: ra73; PMID: 19920251.
24. Yu Z, Huang L, Zhang T, Yang F, Xie L, Liu J, Song S, Miao P, Zhao L, Zhao X, et al. PIM2 phosphorylates PKM2 and promotes Glycolysis in Cancer Cells. The Journal of biological chemistry [Internet] 2013; 288: 35406-16. Available from: http://www. jbc. org/con tent/288/49/35406. short?rssD1&utm_sourceDfeedburn er&utm_mediumDfeed&utm_campaignDFeed: CJBC_ MetabolismC(JBC_Metabolism).
25. Kalaiarasan P, Subbarao N, Bamezai RN. Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamics. J Mol Model [Internet] 2014 [cited 2014 Oct 30]; 20: 2447. Available from: http://www. ncbi. nlm. nih. gov/pubmed/25208557; PMID: 25208557.
26. Robey RB, Hay N. Is Akt the "Warburg kinase"?-Aktenergy metabolism interactions and oncogenesis. Semin Cancer Biol 2009; 19: 25-31; PMID: 19130886.
27. Iqbal MA, Siddiqui FA, Gupta V, Chattopadhyay S, Gopinath P, Kumar B, Manvati S, Chaman N, Bamezai RNK. Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2. Mol Cancer [Internet] 2013; 12: 72. Available from: http://www. pubmedcentral. nih. gov/articlerender. fcgi?artidD3710280&toolDpmcentrez &rendertypeDabstract; PMID: 23837608.
28. Semenza GL. Development of novel therapeutic strategies that target HIF-1. Expert Opin Ther Targets 2006; 10: 267-80; PMID: 16548775.
29. Su H, Bodenstein C, Dumont RA, Seimbille Y, Dubinett S, Phelps ME, Herschman H, Czernin J, Weber W. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res. 2006 Oct 1; 12(19): 5659-67.